ZK-229561

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameZK-229561
Drug Alias NameNVP-ABP008ZK-229561
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis AgBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A